Drug Profile
Prostate cancer vaccine - NuGenerex Immuno-Oncology
Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Antigen Express
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Prostate cancer
Most Recent Events
- 26 Apr 2005 Preclinical data from a media release have been added to the Cancer pharmacodynamics section
- 03 Dec 2003 Data presented at the 18th Annual Scientific Meeting of the International Society for Biological Therapy of Cancer (iSBTc-2003) have been added to the Cancer pharmacodynamics section
- 22 Oct 2003 Preclinical trials in Prostate cancer in USA (unspecified route)